Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 205-216 of 1,743
Drug study icon
CompletedNCT06309277

Of Single and Multiple Oral Doses of GM-1020 for Depression

This study is completed in the United Kingdom. It is testing of Single and Multiple Oral Doses of GM-1020 for Depression.

In United Kingdom
DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Gilgamesh Pharmaceuticals
Condition
Depression
Drug study icon
CompletedEUCTR 2006-000105-38

A definitive multi-centre pragmatic randomised controlled double-blind trial of the clinical and cost effectiveness of mirtazapine and sertraline versus placebo for the treatment of depression in d...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrug
Countries
United Kingdom
Sponsor
King's College London (IOP)
Condition
Depression
Drug study icon
CompletedEUCTR 2006-003659-19

A Double Blind, Placebo- and Active-Controlled, Randomized, Sequential Group, Multiple Dose Study to Examine the Effect of the CRF1-Receptor Antagonist R317573 on 7.5% CO2-Inhalation Induced Anxiet...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Anxiety, DepressionDrug
Countries
United Kingdom
Sponsor
Janssen-Cilag International N.V.
Condition
Anxiety, Depression
Drug study icon
CompletedEUCTR 2018-002782-19

A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF CARIPRAZINE AS AN ADJUNCT TO ANTIDEPRESSANTS IN THE TREATMENT OF PATIENTS WITH MAJOR DEPRESSIVE DISORDER WHO HAVE HAD AN INADEQUATE RESPONSE TO ANTIDEPRE...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, United Kingdom, Bulgaria, ...
Sponsor
Allergan Ltd.
Condition
Depression
Biological study icon
CompletedEUCTR 2014-005206-37

A Double-Blind, Placebo-Controlled, Multicenter Study of Sirukumab as Adjunctive Treatment to a MonoAminergic antidepressant in Adults with Major Depressive Disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
DepressionBiological
Countries
United Kingdom, Poland
Sponsor
Janssen-Cilag International N.V.
Condition
Depression
Biological study icon
CompletedEUCTR 2013-000212-22

A double-blind, randomised, placebo-controlled, parallel group study of GWP42003 as adjunctive therapy in the first line treatment of schizophrenia or related psychotic disorder

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
SchizophreniaBiological
Countries
United Kingdom, Poland, Romania
Sponsor
GW Research Ltd
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.